Skip to main content
OpenTrials

Clinical trial condition

Amyloidosis, Familial

Explore clinical trials studying Amyloidosis, Familial. Study availability and eligibility vary by location and protocol.

22 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

Amyloidosis, Familial trial results

Completed

HELIOS-A: A Study of Vutrisiran (ALN-TTRSC02) in Patients With Hereditary Transthyretin Amyloidosis (hATTR Amyloidosis)

NCT03759379

Conditions
Amyloidosis, Amyloidosis, Familial, Amyloidosis, Hereditary, +8 more
Locations
  • Clinical Trial Site La Mesa, California, United States
  • Clinical Trial Site Aurora, Colorado, United States
  • Clinical Trial Site Jacksonville, Florida, United States
  • Clinical Trial Site Chicago, Illinois, United States
View all 64 locations
View Trial Details
Completed

APOLLO: The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis

NCT01960348

Conditions
Amyloid Neuropathies, Amyloid Neuropathies, Familial, Amyloidosis, +16 more
Locations
  • Clinical Trial Site La Mesa, California, United States
  • Clinical Trial Site Orange, California, United States
  • Clinical Trial Site Denver, Colorado, United States
  • Clinical Trial Site Chicago, Illinois, United States
View all 52 locations
View Trial Details
Completed

Patisiran in Patients With Hereditary Transthyretin-mediated Amyloidosis (hATTR Amyloidosis) Disease Progression Post-Liver Transplant

NCT03862807

Conditions
Amyloidosis, Amyloidosis, Familial, Amyloidosis, Hereditary, Transthyretin-Related, +7 more
Locations
  • Clinical Trial Site Créteil, France
  • Clinical Trial Site Le Kremlin-Bicêtre, France
  • Clinical Trial Site Münster, Germany
  • Clinical Trial Site Messina, Italy
View Trial Details
Completed

A Multicenter Observational Study to Evaluate the Effectiveness of Patisiran in Patients With Polyneuropathy of ATTRv Amyloidosis With a V122I or T60A Mutation

NCT04201418

Conditions
Amyloid Neuropathies, Amyloid Neuropathies, Familial, Amyloidosis, +16 more
Locations
  • Clinical Trial Site Los Angeles, California, United States
  • Clinical Trial Site San Diego, California, United States
  • Clinical Trial Site Aurora, Colorado, United States
  • Clinical Trial Site Farmington, Connecticut, United States
View all 27 locations
View Trial Details
Completed

ENDEAVOUR: Phase 3 Multicenter Study of Revusiran (ALN-TTRSC) in Patients With Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC)

NCT02319005

Conditions
Alzheimer Disease, Amyloid Neuropathies, Amyloid Neuropathies, Familial, +27 more
Locations
  • Clinical Trial Site Bakersfield, California, United States
  • Clinical Trial Site Beverly Hills, California, United States
  • Clinical Trial Site La Mesa, California, United States
  • Clinical Trial Site Los Angeles, California, United States
View all 61 locations
View Trial Details
Completed

The Effect of Diflunisal on Familial Amyloidosis

NCT00294671

Conditions
Amyloid Neuropathies, Amyloid Neuropathies, Familial, Amyloidosis, +14 more
Locations
  • Amyloidosis Center, Boston Medical Center Boston, Massachusetts, United States
  • Mayo Clinic Rochester Rochester, Minnesota, United States
  • Mount Sinai School of Medicine, Department of Medicine New York, United States
  • IRCCS Policlinico San Matteo Pavia, Italy
View Trial Details
Active, Not Recruiting

HELIOS-B: A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

NCT04153149

Conditions
Amyloidosis, Amyloidosis, Familial, Amyloidosis, Hereditary, Transthyretin-Related, +10 more
Locations
  • Clinical Trial Site La Mesa, California, United States
  • Clinical Trial Site Los Angeles, California, United States
  • Clinical Trial Site Stanford, California, United States
  • Clinical Trial Site Washington D.C., District of Columbia, United States
View all 119 locations
View Trial Details

Related conditions